Prestige Wealth Management Group »

Outlook Therapeutics shares owned by Prestige Wealth Management Group

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Prestige Wealth Management Group from 13F filings

Historical chart of Prestige Wealth Management Group investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Prestige Wealth Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Prestige Wealth Management Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $740 62 11.95

More positions owned by Prestige Wealth Management Group

Wisdomtree Tr Us Qtly Div Grt (DGRW)
Ishares Tr Conv Bd Etf (ICVT)
Ishares Tr Broad Usd High (USHY)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Wisdomtree Tr Yield Enhancd Us (AGGY)
Apple (AAPL)
Wisdomtree Tr Us Quality Grow (QGRW)
Select Sector Spdr Tr Financial (XLF)
Colgate-Palmolive Company (CL)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Microsoft Corporation (MSFT)
Vanguard Index Fds Growth Etf (VUG)
Select Sector Spdr Tr Technology (XLK)
Spdr Ser Tr S&P 400 MDCP GRW (MDYG)
Select Sector Spdr Tr Sbi Healthcare (XLV)

View all positions for Prestige Wealth Management Group

Top funds holding Outlook Therapeutics

Tang Capital Management
Dr. Jeffrey R. Jay, M.D.
Armistice Capital
Sphera Funds Management
BlackRock
Velan Capital Investment Management
Caligan Partners
Vanguard Group
Schonfeld Strategic Advisors
Geode Capital Management
Northern Trust
Bank of America Corporation
Walleye Trading Advisors
Hrt Financial
Millennium Management

View all funds holding Outlook Therapeutics